Acarbose
Overview
Acarbose is an oral alpha-glucosidase inhibitor used in managing non-insulin-dependent diabetes mellitus. It delays the digestion and absorption of carbohydrates, thereby reducing postprandial blood glucose excursions.
API suppliers (8)
Suppliers of Acarbose evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 8 suppliers.
2 of 8 hold a GMP certificate on record in the EU or UK registers
- Bayer PlcUnited Kingdom1 active DMF
- Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- CSPC SHENGXUE GLUCOSE CO LTD1 active DMF
- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL JIANGDONG CO LTD1 active DMF
- HEBEI HUARONG PHARMACEUTICAL CO LTDChina1 active DMF
- LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTD1 active DMF GMP on record
- LIVZON NEW NORTH RIVER PHARMACEUTICAL CO LTDChina
- HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDChina
EU CEP holders (6)
Companies holding a valid EU Certificate of Suitability (CEP) for Acarbose, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Acarbose? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.